GD1

GD1, short for Global from Day One, is a New Zealand venture firm whose name is also its operating thesis. Headquartered in Auckland, the fund backs companies that treat their home market as a launchpad rather than a destination, with explicit pressure on founders to design for international customers, regulators, and capital providers from the first product release.

The healthcare focus is concentrated in health IT and healthcare software, digital health, and AI/ML in healthcare. The fund tends to favor companies building tools that improve clinical workflow, reduce administrative load, or apply machine learning to diagnostic and operational problems. AI is core to the thesis rather than incidental; GD1 looks for teams that understand how to ship reliable models inside regulated environments and how to defend a product position against larger incumbents adding AI features. The portfolio leans toward software with embedded clinical or scientific complexity rather than pure consumer-facing apps.

Check sizes run from $1M to $5M, with the fund active across seed, Series A, and Series B. That sweet spot positions GD1 as either a lead or significant participant in early institutional rounds, often partnering with Australian, US, and Asian co-investors as portfolio companies move beyond their initial markets. Founders should expect the fund to push hard on US or other major-market expansion well before late-stage rounds, and to be candid when a company appears to be optimizing for local revenue at the expense of global narrative.

The team brings a mix of operating, investing, and capital markets experience. Diligence tends to be commercial as much as technical, with attention to retention metrics, sales cycle realism, and the credibility of international expansion plans. The firm is comfortable with companies that have early enterprise design partners and clear evidence of pull from beyond New Zealand.

Working with GD1 means an investor that is hands-on with go-to-market questions, fundraising syndication, and governance, and that expects portfolio CEOs to be sharp on metrics. The fund is willing to engage on hiring, particularly for senior commercial roles outside New Zealand, and on connecting portfolio companies to follow-on capital in larger venture markets. Founders who want a passive check or who plan to remain primarily New Zealand-focused are unlikely to be a fit. Founders who are technically credible, commercially ambitious, and willing to absorb hard feedback on whether their plan is actually global will find a partner who treats their company as a serious international business from the day the term sheet is signed. GD1’s working style is direct and metrics-driven, with a clear preference for founders who can defend their plan rather than rely on enthusiasm.